Mersana Therapeutics Completes Merger and Delists from Nasdaq
at www.tipranks.com (Tue, 6-Jan 9:49 AM)
Mersana Shareholders Could Receive Up to $55.25 Per Share in Day One Acquisition—Here’s What the Deal Means
Market Chameleon (Thu, 13-Nov 10:29 AM)
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in Deal Worth Up to $285 Million—Contingent Payments in Focus
Market Chameleon (Thu, 13-Nov 7:05 AM)
